In last decades, many scholars have studied the relationship between aldehyde dehydrogenase 2 (ALDH2) rs671 and ischemic stroke (IS), however, the results obtained from these studies were inconclusive. The purpose of this study was to investigate the association between rs671 and the risk of IS by systematically review.Two researchers independently screened relevant published literatures, derived data and estimated the risk of bias of the research in Pubmed, Embase, Ovid, China National Knowledge Infrastructure (CNKI), Cochrane Library and China Biomedical Literature Database throughout March 29, 2020. All statistical analyses were performed with the Stata 12.0 software. The data of the study was analyzed using fixed and random effects models. The results were expressed by odds ratio (OR) and 95% confidence interval (95%CI).A total of 10 articles were included this study. The total number of samples for all studies was 5265, including 2762 cases and 2503 controls. Statistical results indicated statistical differences between ALDH2 rs671 polymorphism and IS under dominant model (AA vs. AG + GG) and allelic model (A vs G), ORs (95% CI) were 1.66 (1.27-2.17) (P = .00) and 1.34 (1.05-1.71) (P = .02), respectively. But there was no statistical difference under recessive model (AA + AG vs GG), OR (95% CI) was 1.40 (0.99-1.97), P = .06.ALDH2 rs671 polymorphism was related to IS risk for Chinese population and the A allele of rs671 may be a risk factor of IS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249896 | PMC |
http://dx.doi.org/10.1097/MD.0000000000020206 | DOI Listing |
World J Biol Psychiatry
December 2024
Division of Human Genetics, Department of Pathology, University of Cape Town, South Africa.
Objective: The aetiology of epilepsy is known to have genetic contributions, yet results from genome-wide association studies (GWAS) have not always been consistent. We undertook a systematic review in order to identify risk variants for epilepsy.
Methods: This systematic review was conducted in accordance with the PRISMA protocol.
Int J Mol Sci
November 2024
Institute of Advanced Technology, Theragen Health Co., Ltd., Seongnam 13493, Republic of Korea.
Insulin resistance is a major indicator of cardiovascular diseases, including hypertension. The Metabolic Score for Insulin Resistance (METS-IR) offers a simplified and cost-effective way to evaluate insulin resistance. This study aimed to identify genetic variants associated with the prevalence of hypertension stratified by METS-IR score levels.
View Article and Find Full Text PDFPharmacogenet Genomics
December 2024
PhD Program in Environmental and Occupational Medicine, College of Medicine, Kaohsiung Medical University.
Alcohol Clin Exp Res (Hoboken)
November 2024
Center for Birth Cohort Studies, University of Yamanashi, Chuo, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!